A
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A11.9 KBALEXION PHARMACEUTICALS, INC.Aug 9, 3:23 PM ET·0000834237-21-008917
- 8-K347.8 KBALEXION PHARMACEUTICALS, INC.Jul 22, 6:11 AM ET·0001104659-21-094624
- 8-K188.3 KBALEXION PHARMACEUTICALS, INC.Jul 20, 8:20 AM ET·0000899866-21-000061
- 8-K/A220.6 KBALEXION PHARMACEUTICALS, INC.May 13, 8:05 AM ET·0001140361-21-017123
- 8-K213.8 KBALEXION PHARMACEUTICALS, INC.May 11, 4:30 PM ET·0001140361-21-016824
- 8-K246.3 KBALEXION PHARMACEUTICALS, INC.May 4, 4:45 PM ET·0001140361-21-015744
- 10-Q12.0 MBALEXION PHARMACEUTICALS, INC.Apr 30, 8:25 AM ET·0000899866-21-000039
- 8-K470.3 KBALEXION PHARMACEUTICALS, INC.Apr 30, 8:13 AM ET·0000899866-21-000037
- 8-K179.9 KBALEXION PHARMACEUTICALS, INC.Mar 15, 4:10 PM ET·0001140361-21-008493
- 8-K171.4 KBALEXION PHARMACEUTICALS, INC.Feb 16, 5:02 PM ET·0000899866-21-000021
Insiders
10- 667, L.P.Director
- ANDERSON DAVID JEVP, Chief Financial Officer
- Baker Bros. Advisors (GP) LLCDirector
- BAKER BROS. ADVISORS LPDirector
- Baker Brothers Life Sciences LPDirector
- BAKER FELIXDirector
- BAKER JULIANDirector
- Bazarko DanielSVP, Controller, CAO
- BELL LEONARDDirector, CEO
- BOESS CARSTENFormer Chief Financial Officer
Tickers
No tickers on record
Addresses
business
121 SEAPORT BOULEVARD
BOSTON, MA, 02210
mailing
121 SEAPORT BOULEVARD
BOSTON, MA, 02210
Former Names
- ALEXION PHARMACEUTICALS INC2018-06-29